Highlights
Major new cancer vaccine programme (2010)
Maurice Wilkins Centre investigators are involved in a major new research programme that aims to develop and trial anti-cancer vaccines in New Zealand.
read the full story
Virtual screening boosts drug discovery (2010)
A high-powered new virtual environment that allows researchers to screen thousands of molecules as potential new drug leads was launched in 2010, providing a major boost to Maurice
read the full story
Supporting New Zealand’s future scientists (2010)
The inaugural Future Science Day convened by the Maurice Wilkins Centre in 2010 provided advice, mentorship, networking, and science communication opportunities to 150 New Zealand
read the full story
Modern approaches to an ancient disease (2010)
Scientists associated with the Maurice Wilkins Centre have created new drugs for tuberculosis.
read the full story
Mapping cellular networks (2010)
Maurice Wilkins Centre PhD student Daniel Hurley and colleagues are mapping signalling networks in cancer and have identified “master regulators” associated with patient survival.
read the full story
Joining forces against infectious disease (2010)
The 2010 Superbugs Symposium convened by the Maurice Wilkins Centre brought together more than 350 medical professionals and scientists fighting infectious disease.
read the full story
Drug selection a milestone for spin-out (2010)
In 2010 Maurice Wilkins Centre investigators Professors Bill Denny and Peter Shepherd selected a new anticancer drug candidate for clinical development, triggering US $4.5 million
read the full story
Doctoral students win international recognition (2010)
Two medicinal chemistry PhD students supervised by Maurice Wilkins Centre investigator Professor Margaret Brimble have won prestigious international postdoctoral fellowships.
read the full story
Clues to life-threatening organ failure (2010)
Relatively little is known about lymph but there is growing evidence that it can carry disease-causing toxins from the intestines throughout the body. Researchers associated with t
read the full story
Cancer stealth drug enters clinical development (2010)
The first of an exciting new class of anticancer drugs will proceed to clinical development under an international deal announced in early 2011.
read the full story